Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label, phase II study to evaluate the efficacy and safety of biweekly
docetaxel and DeGramont regimen on unresectable gastric adenocarcinoma in the first-line
therapy.